Search

Author/Creator Ekholm, Ella

1. Efficacy and safety of dapagliflozin in addition to insulin therapy in Japanese patients with type 2 diabetes: Results of the interim analysis of 16‐week double‐blind treatment period. Issue 4 (22nd January 2016)

Authors:
Araki, Eiichi; Onishi, Yukiko; Asano, Michiko; Kim, Hyosung; Ekholm, Ella; Johnsson, Eva; Yajima, Toshitaka
Journal:
Journal of diabetes investigation
Issue:
Volume 7:Issue 4(2016:Aug.)
Page Start:
555
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Efficacy and safety of dapagliflozin plus saxagliptin versus insulin glargine over 52 weeks as add‐on to metformin with or without sulphonylurea in patients with type 2 diabetes: A randomized, parallel‐design, open‐label, Phase 3 trial. Issue 6 (23rd February 2020)

Authors:
Vilsbøll, Tina; Ekholm, Ella; Johnsson, Eva; Garcia‐Sanchez, Ricardo; Dronamraju, Nalina; Jabbour, Serge A.; Lind, Marcus
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 22:Issue 6(2020)
Page Start:
957
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Model‐based characterization of the relationship between dapagliflozin systemic exposure and HbA1c response in patients with type 1 diabetes mellitus. Issue 6 (14th March 2019)

Authors:
Parkinson, Joanna; Tang, Weifeng; Åstrand, Magnus; Melin, Johanna; Ekholm, Ella; Hamrén, Bengt; Boulton, David W.
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 21:Issue 6(2019)
Page Start:
1381
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗